Randall Rago

618 total citations
18 papers, 526 citations indexed

About

Randall Rago is a scholar working on Pulmonary and Respiratory Medicine, Oncology and Molecular Biology. According to data from OpenAlex, Randall Rago has authored 18 papers receiving a total of 526 indexed citations (citations by other indexed papers that have themselves been cited), including 9 papers in Pulmonary and Respiratory Medicine, 6 papers in Oncology and 5 papers in Molecular Biology. Recurrent topics in Randall Rago's work include Prostate Cancer Treatment and Research (7 papers), Prostate Cancer Diagnosis and Treatment (4 papers) and Cancer, Lipids, and Metabolism (2 papers). Randall Rago is often cited by papers focused on Prostate Cancer Treatment and Research (7 papers), Prostate Cancer Diagnosis and Treatment (4 papers) and Cancer, Lipids, and Metabolism (2 papers). Randall Rago collaborates with scholars based in United States, Spain and Taiwan. Randall Rago's co-authors include George Wilding, William F. Henry, Maureen O. Ripple, Jacque Mitchen, Terry D. Oberley, Ann‐Lii Cheng, Susan Halabi, Paul R. Hutson, Nicholas J. Vogelzang and Dona Alberti and has published in prestigious journals such as Journal of Clinical Oncology, JNCI Journal of the National Cancer Institute and Cancer.

In The Last Decade

Randall Rago

18 papers receiving 507 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Randall Rago United States 10 247 145 112 107 59 18 526
Kathrin Heermeier Germany 14 386 1.6× 43 0.3× 109 1.0× 116 1.1× 68 1.2× 18 891
G Berge Norway 10 266 1.1× 165 1.1× 197 1.8× 118 1.1× 128 2.2× 22 613
C.-W. Chi Taiwan 17 240 1.0× 69 0.5× 83 0.7× 108 1.0× 42 0.7× 31 705
Camille Mallouh United States 14 225 0.9× 112 0.8× 71 0.6× 101 0.9× 53 0.9× 35 542
Shinichi Ikemoto Japan 14 401 1.6× 144 1.0× 241 2.2× 111 1.0× 36 0.6× 48 902
J.K. Mellon United Kingdom 12 380 1.5× 112 0.8× 168 1.5× 216 2.0× 42 0.7× 20 731
Akihiro Naito Japan 16 443 1.8× 104 0.7× 170 1.5× 193 1.8× 71 1.2× 52 738
Jae Yeon Chun United States 10 180 0.7× 187 1.3× 135 1.2× 136 1.3× 67 1.1× 13 477
Ruisheng Yao United States 17 362 1.5× 87 0.6× 138 1.2× 138 1.3× 55 0.9× 25 597
Charles YF Young United States 13 298 1.2× 149 1.0× 72 0.6× 112 1.0× 105 1.8× 15 603

Countries citing papers authored by Randall Rago

Since Specialization
Citations

This map shows the geographic impact of Randall Rago's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Randall Rago with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Randall Rago more than expected).

Fields of papers citing papers by Randall Rago

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Randall Rago. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Randall Rago. The network helps show where Randall Rago may publish in the future.

Co-authorship network of co-authors of Randall Rago

This figure shows the co-authorship network connecting the top 25 collaborators of Randall Rago. A scholar is included among the top collaborators of Randall Rago based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Randall Rago. Randall Rago is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

18 of 18 papers shown
1.
Rago, Randall, Albert Einstein, Richard M. Lush, et al.. (2003). Safety and efficacy of the MDR inhibitor Incel (biricodar, VX-710) in combination with mitoxantrone and prednisone in hormone-refractory prostate cancer. Cancer Chemotherapy and Pharmacology. 51(4). 297–305. 25 indexed citations
2.
Levine, Ellis, Susan Halabi, John D. Roberts, et al.. (2002). Higher doses of mitoxantrone among men with hormone‐refractory prostate carcinoma. Cancer. 94(3). 665–672. 14 indexed citations
3.
Small, Eric J., Susan Halabi, Mark J. Ratain, et al.. (2002). Randomized Study of Three Different Doses of Suramin Administered With a Fixed Dosing Schedule in Patients With Advanced Prostate Cancer: Results of Intergroup 0159, Cancer and Leukemia Group B 9480. Journal of Clinical Oncology. 20(16). 3369–3375. 44 indexed citations
4.
Church, Dawn R., Yunlei Zhang, Randall Rago, & George Wilding. (1999). Efficacy of suramin against human prostate carcinoma DU145 xenografts in nude mice. Cancer Chemotherapy and Pharmacology. 43(3). 198–204. 5 indexed citations
5.
6.
Rago, Randall. (1998). Management of Hormone-Sensitive and Hormone-Refractory Metastatic Prostate Cancer. Cancer Control. 5(6). 513–521. 10 indexed citations
7.
Hutson, Paul R., Kendra D. Tutsch, Randall Rago, et al.. (1998). Renal clearance, tissue distribution, and CA-125 responses in a phase I trial of suramin.. PubMed. 4(6). 1429–36. 9 indexed citations
8.
Berlin, Jordan, K D Tutsch, Paul R. Hutson, et al.. (1997). Phase I clinical and pharmacokinetic study of oral carboxyamidotriazole, a signal transduction inhibitor.. Journal of Clinical Oncology. 15(2). 781–789. 44 indexed citations
9.
Ripple, Maureen O., George Wilding, William F. Henry, & Randall Rago. (1997). Prooxidant-Antioxidant Shift Induced by Androgen Treatment of Human Prostate Carcinoma Cells. JNCI Journal of the National Cancer Institute. 89(1). 40–48. 266 indexed citations
10.
Janiri, Luigi, et al.. (1997). SSRIs in alcoholism: Fluvoxamine vs fluoxetine in alcoholic outpatients. Biological Psychiatry. 42(1). 35S–35S. 1 indexed citations
11.
Mitchen, Jacque, et al.. (1995). Use of a DNA microfluorometric assay to measure proliferative response of mink lung cells to purified TGFβ and to TGFβ activity found in prostate cell conditioned medium. In Vitro Cellular & Developmental Biology - Animal. 31(9). 692–697. 5 indexed citations
12.
Janiri, Luigi, et al.. (1995). P-10-21 Trazodone as a possible anticompulsive drug in alcoholism: A preliminary study in the post-detoxification period. European Neuropsychopharmacology. 5(3). 399–400. 1 indexed citations
13.
14.
Hutson, Paul R., et al.. (1993). Evidence of an absorption phase after short intravenous suramin infusions. Cancer Chemotherapy and Pharmacology. 31(6). 495–499. 4 indexed citations
15.
Mitchen, Jacque, Randall Rago, & George Wilding. (1993). Effects of suramin on the proliferation of primary epithelial cell cultures derived from normal, benign hyperplastic and cancerous human prostates. The Prostate. 22(1). 75–89. 18 indexed citations
16.
Rago, Randall, Peter C. Brazy, & George Wilding. (1992). Disruption of mitochondrial function by suramin measured by rhodamine 123 retention and oxygen consumption in intact DU145 prostate carcinoma cells.. PubMed. 52(24). 6953–5. 10 indexed citations
17.
18.
Rago, Randall, Jacque Mitchen, Ann‐Lii Cheng, Terry D. Oberley, & George Wilding. (1991). Disruption of cellular energy balance by suramin in intact human prostatic carcinoma cells, a likely antiproliferative mechanism.. PubMed. 51(24). 6629–35. 36 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Kathrin Heermeier Breakdown of academic impact, for papers by G Berge Breakdown of academic impact, for papers by C.-W. Chi Breakdown of academic impact, for papers by Camille Mallouh Breakdown of academic impact, for papers by Shinichi Ikemoto Breakdown of academic impact, for papers by J.K. Mellon Breakdown of academic impact, for papers by Akihiro Naito Breakdown of academic impact, for papers by Jae Yeon Chun Breakdown of academic impact, for papers by Ruisheng Yao Breakdown of academic impact, for papers by Charles YF Young
Rankless by CCL
2026